Burning Rock Biotech (BNR) Equity Ratio (2019 - 2025)

Burning Rock Biotech's Equity Ratio history runs 7 years deep, the most recent figure standing at 0.65 for Q4 2025.

• In Q4 2025, Equity Ratio fell 0.55% year-over-year to 0.65; the TTM figure through Dec 2025 stood at 0.65 (down 0.55% YoY), while the FY2025 annual figure was 0.65, down 0.55% from the prior year.
• Equity Ratio was 0.65 for Q4 2025 at Burning Rock Biotech, down from 0.68 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.87 in Q1 2021 to a low of 0.65 in Q4 2025.
• Historically, Equity Ratio has averaged 0.74 across 5 years, with a median of 0.73 in 2022.
• The sharpest annual moves came in 2022 and 2025: Equity Ratio retreated 11.68% in 2022, then advanced 3.26% in 2025.
• A 5-year view of Equity Ratio shows it stood at 0.81 in 2021, then fell by 9.9% to 0.73 in 2022, then climbed by 1.26% to 0.74 in 2023, then retreated by 11.2% to 0.66 in 2024, then retreated by 0.55% to 0.65 in 2025.
• The last three Equity Ratio figures came in at 0.65 (Q4 2025), 0.68 (Q3 2025), and 0.68 (Q2 2025), per Business Quant data.